Polyclonal Antibody to Von Hippel Lindau Tumor Suppressor (vHL) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPJ769Ra01-Recombinant Von Hippel Lindau Tumor Suppressor (vHL)
Recommended Usage
Western blotting: 0.5-2μg/mL;1:500-2000< br/> Immunohistochemistry: 5-20μg/mL;1:50-200< br/> Immunocytochemistry: 5-20μg/mL;1:50-200< br/> Optimal working dilutions must be determined by end user.
